Searched for
GABAPENTIN TABLETS
Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%- Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%
- Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…
- One simple reason to own & trade them: 5 large-caps from different sectors with upside potential of up to 46%The rising stock price of a company does not mean that the business is strong. And a falling stock price does not mean that the business is...03 Jul, 2025, 12.48 PM IST
- Glenmark, Sun Pharma, Zydus recall products in USGlenmark, Sun Pharma, and Zydus are recalling various products in the US due to manufacturing issues and CGMP deviations, according to the ...13 Apr, 2025, 11.11 AM IST
- Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has annou...03 Apr, 2025, 06.56 PM IST
- Pharma: Stay bullish, but hedge to avoid mistake of selling due to deadline. 7 stocks with upside potential of up to 50%While Democrats are better known to push for lower drug prices in the US, in recent times even Republicans are talking about keeping the co...22 Mar, 2025, 06.29 PM IST
- Listen beyond the noise from Trump, think beyond Nifty’s volatility: 8 mid and 1 small cap pharma stock with upside potential of up to 46%With the Nifty moving up for just two days, have we forgotten what happened to stock prices in the past six months? This is where we all ma...05 Mar, 2025, 03.40 PM IST
- Look for good quality businesses at relatively lower valuations: 5 large-caps from different sectors with upside potential of up to 44%Our headline says “relatively” lower valuations. Now, “relatively” is used in two contexts. A stock that was trading at a PE of 93 is today...27 Feb, 2025, 08.46 PM IST
- These large- and mid-cap stocks can give more than 28% return in 1 year, according to analystsWhich is the one word that has dominated equity markets for the past five months? Volatility. For a majority, it is a bad word that is asso...14 Feb, 2025, 06.04 AM IST
- Decline in rupee: Besides IT, there are other winners as well; 9 pharma stocks with an upside potential of up to 40%The relationship between a decline in the rupee and better margins for IT companies is well known. What is not discussed much is that pharm...14 Jan, 2025, 02.13 PM IST
- Zydus gets USFDA nod for generic medicationZydus Lifesciences announced that it has obtained approval from the USFDA to sell a generic medication for the treatment of postherpetic ne...25 Jan, 2024, 03.47 PM IST
- Granules India receives USFDA approval for generic gabapentin tabletsThese tablets are bioequivalent to the reference listed drug product, Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty LLC.29 Mar, 2023, 05.21 PM IST
- Glenmark Pharma gets USFDA nod for erectile dysfunction treatmentGlenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Tadalafil tablets ...31 Dec, 2020, 11.12 AM IST
- Bidencare, a boost for Indian pharmaceutical companiesThe Indian pharma sector is expected to benefit from the Biden presidency on the back of an increased push for generic prescriptions and ac...09 Nov, 2020, 10.54 AM IST
- Lupin gets USFDA nod to market its postherpetic neuralgia drugThe company's tablets are generic version of Pfizer Inc's Neurontin tablets in the same strengths, Lupin said.28 Aug, 2018, 02.22 PM IST
- Glenmark recalls three drugs from US marketGlenmark Generics is recalling multiple lots of three of its drugs from the US market due to "odd smell", according to US FDA.23 May, 2013, 05.41 PM IST
- Ranbaxy recalls Nitrofurantoin capsules from US marketThe drug is an antibiotic commonly used to treat urinary tract infection.02 May, 2009, 09.44 AM IST
- Ranbaxy units face FDA heat after inspectionsSources said that USFDA has given a ‘not approved’ rating to new products manufactured at the facility, although this could not be independ...02 Jul, 2008, 03.42 AM IST
- Ranbaxy recalls 73 million pills from US marketThe company recalled Gabapentin tablets after discovering impurities outside the approved specification limit. Day in pics | Master your tr...16 Nov, 2007, 09.00 PM IST
Load More
